Greenspring Advisors’s Eli Lilly LLY Stock Holding History

Greenspring Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.86M	Buy	3,107 +66	+2%	+$66.9K	0.17%	70
2025 Q4	$3.27M	Buy	3,041 +2,541	+508%	+$2.43M	0.2%	67
2025 Q3	$382K	Buy	+500	New	+$372K	0.07%	72
2025 Q1	$1.23M	Buy	1,490 +250	+20%	+$208K	0.29%	31
2024 Q4	$957K	Sell	1,240 -250	-17%	-$207K	0.21%	33
2024 Q3	$1.32M	Hold	1,490	–	–	0.29%	25
2024 Q2	$1.35M	Buy	1,490 +190	+15%	+$152K	0.32%	22
2024 Q1	$1.01M	Hold	1,300	–	–	0.25%	27
2023 Q4	$758K	Hold	1,300	–	–	0.21%	28
2023 Q3	$698K	Buy	1,300 +800	+160%	+$412K	0.22%	28
2023 Q2	$234K	Sell	500 -1,552	-76%	-$651K	0.07%	56
2023 Q1	$705K	Sell	2,052 -148	-7%	-$49.9K	0.15%	56
2022 Q4	$805K	Hold	2,200	–	–	0.21%	50
2022 Q3	$711K	Hold	2,200	–	–	0.22%	50
2022 Q2	$714K	Hold	2,200	–	–	0.21%	49
2022 Q1	$630K	Sell	2,200 -8	-0.4%	-$2.06K	0.17%	51
2021 Q4	$610K	Buy	+2,208	New	+$560K	0.16%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Greenspring Advisors's LLY Position: Q1 2026 in Review

Greenspring Advisors increased its Eli Lilly (LLY) stake by 2.2% in Q1 2026, buying an estimated $66.9K and bringing the position to 3,107 shares worth $2.86M. The position accounts for 0.17% of the portfolio, ranked #70.

Greenspring Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.27M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Greenspring Advisors held 3,107 shares of Eli Lilly worth $2.86M as of Q1 2026.
Greenspring Advisors bought 66 Eli Lilly shares in Q1 2026, an estimated $66.9K.
Eli Lilly made up 0.17% of Greenspring Advisors's portfolio in Q1 2026, its #70 holding.
Greenspring Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
Greenspring Advisors's Eli Lilly position peaked at $3.27M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.